Sponsor of the Day:
Jerkmate
https://www.veeva.com/resources/veeva-and-biomarin-form-long-term-strategic-partnership/
Veeva and BioMarin Form Long-Term Strategic Partnership | Veeva
Apr 7, 2026 - Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapies.
long term strategicveevabiomarinformpartnership
https://www.biomarin.com/
BioMarin Pharmaceutical | Global Biotechnology Company
Apr 27, 2026 - BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare...
global biotechnology companybiomarinpharmaceutical
https://www.biopharmadive.com/news/biomarin-fda-hemophilia-gene-therapy-resubmit-application/633066/
BioMarin resubmits its hemophilia gene therapy to the FDA | BioPharma Dive
The resubmission has been long awaited after BioMarin’s original application was unexpectedly rejected by the FDA two years ago. The company expects a decision...
gene therapybiopharma divebiomarinresubmitshemophilia
https://www.medtechdive.com/news/biomarin-taps-invitae-to-expand-genetic-testing-for-skeletal-dysplasia/568864/
BioMarin taps Invitae to expand genetic testing for skeletal dysplasia | MedTech Dive
As it develops drug treatment for a form of skeletal dysplasia, BioMarin is bankrolling a program in which medical genetic testing company Invitae will screen...
genetic testingmedtech divebiomarintapsinvitae
https://h1.co/story/advancing-inclusive-clinical-research-for-rare-diseases-at-biomarin/
Advancing Inclusive Clinical Research at BioMarin
See how BioMarin advances inclusive research for rare disease trials through technology for better site selection.
advancing inclusiveclinical researchbiomarin
https://www.biomarin.com/science/medicines/
Medicines | BioMarin
Apr 27, 2026 - BioMarin provides eight treatment options for people living with genetically defined conditions. Learn more about our medicines here.
medicinesbiomarin